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Introduction
Juvenile scleroderma (JS), represents a rarely seen group
of connective tissue disease with multiple organ involve-
ment. Although quite rare in childhood, cardio-vascular
and pulmonary involvements are the most important
mortality and morbidity factors. Pulmonary arterial
hypertension (PAH), the most important sequelae of pul-
monary involvement, could be determined by echocar-
diographic examinations. Early cardio-vascular and
pulmonary involvement determination is extremely
important in reducing mortality of patients
Objectives
The aim of the study was to use non-invasive methods
(echocardiography, pulmonary function tests) to examine
cardio-pulmonary involvement of the disease in patients.
Treatment of patients with positive findings in the early
stage of the disease possibly reduces the morbidity and
mortality.
Methods
Totally of 35 patients with scleroderma, followed up at
Cerrahpasa Medical Faculty, Pediatric Rheumatology
Department with diagnosis of juvenile scleroderma were
included in the study. Doppler echocardiography was
performed at Cerrahpasa Medical Faculty, Pediatric Car-
diology Department and pulmonary function tests were
performed at Laboratory for pulmonary function tests at
Cerrahpasa Medical Faculty. FVC and DLCO were mea-
sured in order to investigate pulmonary fibrosis. The
assessment of PAP and risk factors for PAH was made
by measurement of maximum tricuspid insufficiency
(TI), end diastolic pulmonary insufficiency (PI), AT/ET,
RAP and contraction of vena cava inferior during
inspiration.
Results
The values of TI, PI, AT/ET and PAP were found to be
normal and statistically signıficant different from the
pathological values. The results of FVC and DLCO were
found to be statistically significant above normal values.
In other words, no patient was found to have cardio-
pulmonary involvement.
Conclusion
Although quite rare in juvenile scleroderma, cardio-vas-
cular and pulmonary involvement is the most important
factor in the prognosis of the disease. Early diagnosis,
regular follow up and appropriate treatment are impor-
tant in reducing the cardio-vascular and pulmonary
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